Perspectives from Los Angeles County Tuberculosis Control Program

Slides:



Advertisements
Similar presentations
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
Advertisements

PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
HIV Epidemiology Program: Epidemiology of HIV and AIDS in Los Angeles County Presentation to Public Health Commission October 28, 2010 Douglas M. Frye,
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
1 Measles in Fraser Health Michelle Murti, MHO Fraser Health Authority, BC CPHA May 27, 2014.
B WAIVERS: A YEAR IN REVIEW MARCH 20, 2014 MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE PREVENTION AND HEALTH PROMOTION ADMINISTRATION ANDREA E. PALMER,
Tuberculosis Cluster Investigations Using Genotyping Data Frank Romano, MPH CDC Public Health Advisor.
Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
Using Genotype Data to Detect Outbreaks Tambi Shaw, MPH, Chief Outbreak Prevention and Control Section Tuberculosis Control Branch California Department.
Investigating Foodborne Disease Outbreaks: The CDC Perspective Ian Williams, PhD, MS Chief, Outbreak Response and Prevention Branch Division of Foodborne,
TB Outbreak in Grand Forks
The Public Health Applications of Molecular Epidemiology: Use of HIV-1 Pol Sequences to Identify HIV Transmission Networks in Los Angeles County Jennifer.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Using Phylogenetic Analysis to Identify HIV Transmission Channels among Persons Newly Diagnosed with HIV-1 Infection in Los Angeles County, Kwa.
San Francisco Department of Public Health HIV Partner Services Update 2011 San Francisco STD Prevention and Control Services May 2011.
Unit 8: Uses and Dissemination of HIV Sentinel Surveillance Data #3-8-1.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
DrugEpi 1-4 Counting HS Marijuana Use Module 1 Overview Context Content Area: Descriptive Epidemiology & Surveillance Essential Question (Generic): How.
Tuberculosis Treatment Completion Among Persons Incarcerated at Diagnosis, U.S. TB Surveillance System, 1999–2008 Kiren Mitruka, MD, MPH (presented on.
United States Department of Agriculture Food Safety and Inspection Service FSIS Foodborne Illness Investigations: Current Thinking Scott A. Seys, MPH Chief,
1 How Complete is California’s HIV Status Determination Among 2008 TB Cases? Darryl Kong, MPH TB Control Branch California Department of Public Health.
Introduction to Tuberculosis Genotyping National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination.
State and Local STD Prevention Programs Prepared by Jim Lee, Senior Public Health Advisor, Texas Department of State Health Services and Melinda Salmon,
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Severe Acute Respiratory Syndrome (SARS) AA Model for Preparedness for Emerging Diseases Finding and Filling Gaps.
Epi Program Overview Disease Surveillance and Reporting.
User Resources for the: One Health Harmful Algal Bloom System (OHHABS) and National Outbreak Reporting System (NORS) Updated: 06/15/2016.
National Tuberculosis Genotyping Service
Name(s) Here Job Title(s) Here.
Hepatitis C Virus Program in Chicago
TB Genotyping and Whole Genome Sequencing in California
Los Angeles County TBCP
Lead Poisoning Cases Identified
Whole-Genome Sequencing; It’s Not Just For Epis
EIS The Epidemic Intelligence Service
Roles and Responsibilities of VDH Epidemiologists
Training structure EFFO Ebola Safety and good quality work
CSTE Applied Epidemiology Fellow
Utah Zika investigation, July 2016
Detectives in the Classroom - Investigation 4-5: Concept Connections
Outbreak Management and Notifiable Disease Surveillance System Integration: Merlin and the Merlin Outbreak Module Janet Hamilton, MPH Communicable Disease.
Nucleic Acid Amplification Test for Tuberculosis
Intro to Epidemiology - Investigation 2-1: The 2x2 Table
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Illustrating HIV/AIDS in the United States
Sarah Siddiqui, MD, MPH University of Texas Medical Branch
Committee Task Statement (1)
Mark Lobato, MD Division of TB Elimination
NMCSD Measles Case Investigation
Occupational Health Working together.
Needs Assessment Slides for Module 4
Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing  T.M. Walker, P. Monk, E. Grace Smith, T.E.A.
Using Whole Genome Sequencing Analysis in California
Intro to Epidemiology - Investigation 2-6: The Journey
Division of Tuberculosis Elimination
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Laura Lane, Epidemiologist
Illustrative Cluster Detection and Response Strategy
Lab Results + RVCT Notification=
Surveillance: From Patient to CDC
Uses of Genotyping.
CIFOR Guidelines for Foodborne Disease Outbreak Response and the CIFOR Toolkit: Focus Area 6: Initial Steps of an Investigation New York Integrated Center.
Presentation transcript:

Using Whole Genome Sequencing Analysis in Genotype Cluster Investigation Perspectives from Los Angeles County Tuberculosis Control Program Wendy Noboa, MS Shameer Poonja, MPH Public Health Advisor The Centers for Disease Control and Prevention

Conflict of Interest Statement I have no conflicts of interest to declare.

Objectives Los Angeles County’s (LAC) process of integrating Whole Genome Sequencing (WGS) data into genotype cluster investigation practices Case studies using WGS analysis Identify outbreaks and outbreak cases with greater precision Refute outbreaks Intervene to interrupt recent TB transmission Explore added value, advantages, and challenges of using WGS analysis

Integrating WGS into Genotype Cluster Investigations

LAC’s Genotype Investigation Process When a genotype cluster is identified as a priority it is assigned to a LAC staff member for investigation 1 Genotype cluster investigation process begins by gathering data on all cluster cases 2 Assess the likelihood of recent transmission or the potential for a TB outbreak 3 Review epidemiological data alongside WGS data 4 Based on results of investigation, public health intervention is discussed or resources are reallocated 5

Requesting WGS Analysis Criteria for requesting WGS phylogenetic analysis: Cluster is of high suspicion for ongoing recent transmission Cluster is a potential TB outbreak (Outbreak = 4 cases with definite epi-links within 3 year period) Cluster is rare or unique to LAC What can WGS analysis help answer: Confirm or refute the presence of a TB outbreak Exclude cases that are genetically distant and not associated with recent transmission Identify and focus interventions

Real-world Case Studies

Genotype Cluster A Cluster of 12 cases 9 cases were born outside of the US in Central America 10 cases live within the same neighborhood 7 cases had definite epi-links Family members 2 children <5 years Co-workers in the construction industry Social media Cluster hypothesis: Index case transmitted TB to his sister and a co- worker. Index’s sister then gave it to two social contacts and their children. Two cases work in construction industry and suspected to be in the same chain of transmission as the Index case.

Genotype Cluster A Cases with this shared genotype were originally assumed to be in the same chain of recent transmission 9 18 8 MRCA 7 2 7 2 3 6 6 2 Case with definite epi-link 1 11 10 Case with no known epi-link 10 Non LA County 7 12

Identify how this case might be linked to the outbreak Genotype Cluster A Lessons Learned: Identify how this case might be linked to the outbreak 9 18 Epi-linked cases are within 0-3 SNPS suggesting recent transmission and helping confirm outbreak 8 MRCA Outlier cases with no epi-links are excluded (not recent transmission) 7 2 Non-LAC cases have TB genetically distant from outbreak strain = multijurisdictional outbreak unlikely 7 2 3 6 6 2 1 11 10 10 One case with no known epi-links but genetically similar to other outbreak cases. Warrants intensified investigation Case with definite epi-link Non LA County Case with no known epi-link 12 Additional public health intervention can be supported for all outbreak cases

Genotype Cluster B Homeless US born Homeless Drug use Incarceration HIV + Homeless Drug use US born Incarceration US born 2009 2009 2009 2010 2010 2012 2014 2016 2016 HIV + Homeless Drug use Incarceration Alcohol use US born Alcohol use Homeless US born Homeless Drug use Incarceration Alcohol use US born No known risk factors

Genotype Cluster B 2016 2010 2 3 2010 1 2009 1 9 5 2016 2009 1 1 2014 2 2 2009 2012

Genotype Cluster B HIV + Homeless Homeless Drug use Drug use US born Genotype Cluster B Homeless Drug use Incarceration US born 2016 2010 2 3 No known risk factors 2010 1 2009 Alcohol use 1 HIV + Homeless Drug use Incarceration Alcohol use US born Homeless US born 5 2016 Homeless US born Homeless Drug use Incarceration Alcohol use US born 2009 1 2014 2 2 Incarceration US born 2009 2012

Genotype Cluster B Sub-cluster A Sub-cluster B 2016 2010 2010 2009 2014 2009 2012

Advantages and challenges of using WGS data

Advantages of Using WGS Data Helps confirm or refute TB outbreaks Identify cases in the same chain of recent transmission Exclude cases not in the same chain of recent transmission Helps to focus genotype cluster investigations Phylogenetic trees are a visual tool to share evidence of recent transmission and influence the use of public health resources

Challenges of Using WGS Data WGS data can be intimidating Technical terms and concepts WGS data alone cannot be used to determine directionality of transmission Detailed and complete epidemiologic and clinical data is needed If WGS does not support hypothesis Back to the drawing board to reassess transmission event To get the full picture, WGS analysis may require special requests Retrospective WGS Requests for isolates outside the local jurisdiction Requests for isolates from closely related genotypes

Conclusions WGS is a tool that can be used in conjunction with traditional epidemiologic investigation methods Documentation of clinical and epidemiological data is necessary for WGS analysis Request WGS analysis Work closely with the State TB Control Branch to determine which isolates are most appropriate to request for WGS analysis Do not be intimidated Incorporating WGS analysis does not require a team of investigators The State TB Control Branch can help with interpreting results and training and the Centers for Disease Control and Prevention has a number of scientific resources We are all learning together

Acknowledgements Los Angeles County Tuberculosis Control Program California State TB Control Branch CDC Division of TB Elimination CDC Division of TB Elimination - Surveillance, Epidemiology and Outbreak Investigations Branch CDC Center for State, Tribal, Local, and Territorial Support – Public Health Associate Program Contact Information: Wendy Noboa, PHA, (213) 745-0825, wpernal@ph.lacounty.gov Shameer Poonja, PHA, (213) 745-0834, spoonja@ph.lacounty.gov

BACK UP SLIDES